CRISPR Therapeutics AG (NASDAQ:CRSP)
| 56.76 Delayed Data As of 4:00pm ET |  -1.35 / -2.32%Today’s Change | 30.75 Today|||52-Week Range 74.00 | -6.81% Year-to-Date |
Latest CRSP News | Press Releases
| Better Buy: Vertex Pharmaceuticals vs. Incyte Feb 19 / MotleyFool.com - Paid Partner Content | First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results Feb 07 / MotleyFool.com - Paid Partner Content |
| CRISPR Therapeutics Reports Q4 Earnings, Beats Revenue Expectations Feb 12 / MotleyFool.com - Paid Partner Content | If You Invested $100 in CRISPR Therapeutics' IPO, This Is How Much Money You'd Have Now Feb 07 / MotleyFool.com - Paid Partner Content |
